Juvenile Myoclonic Epilepsy (JME) patients do not always respond to disease modifying medications and continue having seizures that significantly disrupt their daily routine. Examining the event-related-potential (ERP) signals of drug-responsive JME patients compared to nonresponsive ones, we can identify the electrical activity underlying the differences between the two groups. The  gold-standard method for analysing ERP signal has not been re-evaluated regarding the quality of the final signal produced. In this project, we propose a new method for analyzing ERP signals, through which we are able to distinguish JME patients from Healthy Controls, as well as drug-responsive JME patients from nonresponsive ones, and offer new insights into the mechanism of brain activity in drug-responsive JME patients.